Académique Documents
Professionnel Documents
Culture Documents
Dr. med. Frans Santosa, MD, SpJP, EFMA, FACA, FICA, FASA, FIHA, SFGISA
Internist (SpPD) University of Giessen, Germany 1989 Cardiologist (SpJP) University of Giessen Max Planck Society Bad Nauheim, Germany 1991 Angiologist (SpKed.Vask) University of Essen, Germany 2000
PIT IDI Wil DKI Jakarta Hotel Sahid Jakarta, 10 Mei 2012
Cuff sizes
Neonates Infants School children Adults Size of cuff (cm) Width Length 2.5 4 5 10 68 9 10 12 13 12 13.5 17 22.5 22 23.5
Muscular Adults
Obese Adults
15.5
18
30
36
Nilai Target BP
Cerebral
Headache Vomitting Blurring of vision Agitation Decreased consciousness Temporary or permanent paresis Pyramidal signs Comma Generalized seizures
Cardial
Classification of Hypertension
I. By Aetiology
I. Primary Hypertension (85 90%) = essential, idiopathic, genuine, neurogenic II.Secondary Hypertension (10 15%)
A. Renal hypertension
1. Renal vascular hypertension (1%) Renal artery stenosis Renal artery aneurysm Renal artery atherosclerosis 2. Renal parenchymal hypertension (8-12%) Glomerulonephritis Pyelonephritis Polycystic kidney Phenacetin kidney
B. Endocrine hypertension
Cushings syndrome Conns syndrome Pheochromocytoma Hyperthyroidism
Classification of Hypertension
II. By haemodynamic criteria
1. Increased peripheral vascular resistance (resistance hypertension) 2. Minute volume hypertension 3. Due to loss of elasticity (elasticity hypertension)
III. By staging
1. Benign Hypertension which does not/has not manifested in organ damage 2. Malignant Persistent hypertension with a diastolic pressure >120 mm Hg, as manifested by changes in the fundi (KW III, IV)
Classification of Hypertension
V. By character 1. Labile Intermittently elevated blood pressure 2. Stable Persistently elevated blood pressure readings (systolic or diastolic) without the characteristics of malignant hypertension
Brown M, Buddle M, Martin A (2001) Is resistant hypertension really resistant? Am J Hypertens 14: 1263-1269 Der Internist 1, Band 50. Heft 1. Januar 2009 - Hal.8
No mental, nor physical exertion at least 10 minutes before the measurement The cuff must be placed tightly around the arm Look up the correct cuff size below The arm should not be restricted by clothes Inflate cuff until the radial pulse disappears Velocity of deflation: 2 mm Hg/ sec The systolic pressure is read on the first audible pulse The diastolic pressure is read when the audible pulse disappears
Source : HOT, ALL HAT, LIFE, PROGRESS, HOPE, FEVER, ADVANCE, dll
HOT STUDY
N 18790 (usia maks.80, min.50 th, mean 61,5 th) BP 105-115 mm Hg diastolis. mean 169,5 / 105,4 mm Hg. Masa Pengamatan : 3,8 th.
3 Therapi Gol :
Hasil :
-Insident Kejadian Kardiovaskuler terendah pada BP 138,5 / 82,6 mm Hg -Mortalitas Kardiovaskuler terendah pada BP 138,8 / 86,5 mm Hg Ini berarti tambah kuat BP diturunkan tambah rendah mortalitas
-Insident kejadian miokard infark terendah pada BP sistolis 142,2 mm Hg -Insident kejadian stroke terendah pada BP diastolis < 80 mm Hg -68 % dari semua pasien membutuhkan minimal 2 jenis obat anti hipertensi.
Source : Hansson et al, Lancet 351, 1752-1762,1998
HYVET
HYpertension in the Very Eldery Trial
n = 8123 n = 3845
Usia: 80 th s/d 104 th, x 84 th Kriteria: Usia 80 th, BP 160 mmHg TBP:<150/80mmHg Lama pengamatan: 2,1 th Goal of study: Primer : stroke Sekunder: - dead - dead e.c. kardial / vaskuler
Source: Bechett NS, Peters R, Fletchen AE et al; N. Engl J Med 2008, 358: 1887 - 1898
Diagnostik
Pemeriksaan BP Pemeriksaan DL, UL, K, Na, Kreatinin, Ureum EKG Echocardiografi Funduskopi
Source: Evidence Based Treatment in Cardiology; D. Stroedter, F. Santosa, UNIMED Verlag AG 2009: 74
Classification of Beta-blockers
Source: Evidence Based Treatment in Cardiology; D. Stroedter, F. Santosa, UNIMED Verlag AG 2009: 74
Classification of calcium-antagonist
Source: Evidence Based Treatment in Cardiology; D. Stroedter, F. Santosa, UNIMED Verlag AG 2009: 74
Beta blocker
Ca-Antagonis
ACE Inhibitor
Graviditas Batuk Hiperkalemi Arteri renalis stenosis bilateral Mahal Graviditas Hiperkalemi Arteri renalis stenosis bilateral
Consequence
Patient cannot work, thus refusing compliance
Lack of compliance
Solution
Use less sedative agents or use combination therapy
Better patient education, pamphlets Furosemide diuretics
7. Thiazide diuretics Insufficient blood given to patients with Cr pressure control > 2 mg
Combination therapy
I. Optimal combinations
ACE-I / Diuretics AT-I-DRB / Diuretics Beta blockers / Diuretics Cave : DM new manifestasi!!! ACE-I or AT-I-RCB / CCB / HCT Beta blockers / CCB (dihydropyridines) / hydralazine, etc Beta blockers / ACE-I or AT-IRCB
Reason
Diuretics increase Renin, which are influenced by ACE-I Synergism, blunting effects, decreased side effects due to lower dosages See above Synergism due to decreased cardiac output, PVR, avoidance of cardiac sensations (palpitations, AP) Synergism, blunting effects of RAAS
Combination therapy
II. Ocassionally optimal combinations
Reserpin / Methyldopa Beta blockers / Reserpin Beta blockers / CCB (verapamil)
Concerns
May cause depression May cause Bradycardia AV-block or more pronounced bradycardia
Reasons
Similar pharmacodynamics, reduced cardiac output. Both result in bradycardia Reflex tachycardia, palpitations, flushing
Combination of Vasodilators
Differences in Opinion
LVH
NORMAL
Ketebalan IVS = 13.6 mm LVPW = 14.2 mm
Post PTA
Pre PTA
Stroke MI PAOD
Invalid dini Kualitas Hidup Kematian dini
s
0 3 5 140 5 3 0
0 = Jangan merokok 3 = 30 menit olah raga proporsional setiap hari
Key Messages
For persons over age 55, SBP is more important than DBP as CVD risk factor Normotensive individuals at age 55 have a 90% lifetime risk for developing hypertension Those with SBP of 120 mm Hg and DBP of 80 mm Hg should be considered prehypertensive; they may require lifestyle modifications to prevent CVD
Terapi kombinasi bertujuan mendapat efek sinergism dan mereduksi efek samping obat
Pada pasien hipertensi usia sangat lanjut 80 th, menurunkan BP menjadi 150 / 80 mmHg selama 2 tahun terus menerus dapat menurunkan kematian, stroke dan payah jantung
Terima kasih !
Salam dari :
PB IDI IDI Wilayah DKI Jakarta Yayasan Pembuluh Darah (Angiologi) Indonesia Perhimpunan Angiologi Indonesia (PANGI) German Indonesian Society of Angiology Rekayasa Jaringan Sel Indonesia (REJASELINDO)